Search Results - "Mendy, Anthony"

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation by Adigweme, Ikechukwu, Akpalu, Edem, Yisa, Mohammed, Donkor, Simon, Jarju, Lamin B, Danso, Baba, Mendy, Anthony, Jeffries, David, Njie, Abdoulie, Bruce, Andrew, Royals, Michael, Goodson, James L, Prausnitz, Mark R, McAllister, Devin, Rota, Paul A, Henry, Sebastien, Clarke, Ed

“…New strategies to increase measles and rubella vaccine coverage, particularly in low- and middle-income countries, are needed if elimination goals are to be…”
Get full text

Conducting clinical research in a resource-constrained setting: lessons from a longitudinal cohort study in The Gambia by Imam, Abdulazeez, Wariri, Oghenebrume, Dibbasey, Tida, Camara, Abdoulie, Mendy, Anthony, Sanyang, Assan N, Ceesay, Masaneh, Jallow, Samba, Jallow, Abdoulie E, Bah, Kaddijatou, Johnson, Njilan, Trawally, Ebrima, Sowe, Dawda, Darboe, Alansana, Kampmann, Beate, Idoko, Olubukola T

“…Clinical research conducted to Good Clinical Practice (GCP) standards is increasingly being undertaken in resource-constrained low-income and middle-income…”
Get full text

A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial by Adigweme, Ikechukwu, Yisa, Mohammed, Ooko, Michael, Akpalu, Edem, Bruce, Andrew, Donkor, Simon, Jarju, Lamin B, Danso, Baba, Mendy, Anthony, Jeffries, David, Segonds-Pichon, Anne, Njie, Abdoulie, Crooke, Stephen, El-Badry, Elina, Johnstone, Hilary, Royals, Michael, Goodson, James L, Prausnitz, Mark R, McAllister, Devin V, Rota, Paul A, Henry, Sebastien, Clarke, Ed

“…Microneedle patches (MNPs) have been ranked as the highest global priority innovation for overcoming immunisation barriers in low-income and middle-income…”
Get full text

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation T by Adigweme, Ikechukwu, Akpalu, Edem, Yisa, Mohammed, Donkor, Simon, Jarju, Lamin B, Danso, Baba, Mendy, Anthony, Jeffries, David, Njie, Abdoulie, Bruce, Andrew, Royals, Michael, Goodson, James L, Prausnitz, Mark R, McAllister, Devin, Rota, Paul A, Henry, Sebastien, Clarke, Ed

“…New strategies to increase measles and rubella vaccine coverage, particularly in low- and middle-income countries, are needed if elimination goals are to be…”
Get full text

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial] by Adigweme, Ikechukwu, Akpalu, Edem, Yisa, Mohammed, Donkor, Simon, Jarju, Lamin B, Danso, Baba, Mendy, Anthony, Jeffries, David, Njie, Abdoulie, Bruce, Andrew, Royals, Michael, Goodson, James L, Prausnitz, Mark R, McAllister, Devin, Rota, Paul A, Henry, Sebastien, Clarke, Ed

“…Background New strategies to increase measles and rubella vaccine coverage, particularly in low- and middle-income countries, are needed if elimination goals…”
Get full text